As most cancers develop in adulthood, data from short-term studies provide limited information on cancer risk following childhood GH treatment and, therefore, large-scale, long-term follow-up studies on cancer risk remain of ongoing importance (19, 20). This evidence concerns the gene GH1 and cancer.